Related Experiment Videos
[Ductal carcinoma in situ]
Isaac Roisman1, Isaac Lifshitz, A Bitterman
1Department of Surgery A, Lady Davis, Carmel Medical Center, Bruce Rappaport Faculty of Medicine, Haifa, Israel.
Harefuah
|April 7, 2004
Summary
Ductal carcinoma in situ (DCIS), a common non-invasive breast cancer, is increasingly detected by mammography. Early detection and management of these premalignant lesions can prevent invasive breast cancer development.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Ductal carcinoma in situ (DCIS) detection has increased due to widespread mammography screening.
- DCIS is a non-invasive breast lesion often presenting as microcalcifications.
- Premalignant breast lesions highlight the importance of early intervention.
Purpose of the Study:
- To present the current management strategies for ductal carcinoma in situ.
- To emphasize the significance of early detection and local control of breast lesions.
Main Methods:
- Review of current clinical practices and guidelines for DCIS management.
- Analysis of diagnostic methods, including mammography and biopsy.
- Discussion of treatment options for ductal carcinoma in situ.
Main Results:
- Mammography facilitates earlier detection of DCIS, often as microcalcifications.
- DCIS represents a critical stage where intervention can prevent invasive disease.
- Current management focuses on local control and preventing progression.
Conclusions:
- Early identification and management of DCIS are crucial for preventing invasive breast cancer.
- Local removal of premalignant lesions like DCIS is a key strategy in breast cancer control.
- Understanding and applying current DCIS management protocols are vital for patient outcomes.